{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T13:07:56Z","timestamp":1762607276031,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000883","name":"University of Bristol","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000883","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.dsx.2018.07.002","type":"journal-article","created":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T12:50:20Z","timestamp":1531831820000},"page":"3057-3063","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Among young Sri Lankan patients with diabetes, how do lipid profiles differ between those with and without metabolic syndrome?"],"prefix":"10.1016","volume":"13","author":[{"given":"Gaya W.","family":"Katulanda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harsha A.","family":"Dissanayake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasad","family":"Katulanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Shine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2018.07.002_bib1","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00132577-200512000-00018","article-title":"Diagnosis and management of the metabolic syndrome: an American heart association\/national heart, lung, and blood institute scientific statement: executive summary","volume":"4","author":"Grundy","year":"2005","journal-title":"Crit Pathw Cardiol"},{"key":"10.1016\/j.dsx.2018.07.002_bib2","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report","volume":"106","author":"Third report of the National Cholesterol Education Program (NCEP) expert panel on detection","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.dsx.2018.07.002_bib3","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome\u2013a new world-wide definition. A consensus statement from the International Diabetes Federation","volume":"23","author":"Alberti","year":"2006","journal-title":"Diabet Med"},{"key":"10.1016\/j.dsx.2018.07.002_bib4","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/archinte.164.10.1066","article-title":"Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women","volume":"164","author":"Hu","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.dsx.2018.07.002_bib5","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1161\/01.CIR.0000140762.04598.F9","article-title":"National cholesterol education program versus world Health organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the san antonio heart study","volume":"110","author":"Hunt","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.dsx.2018.07.002_bib6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2337\/diacare.28.2.385","article-title":"The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study","volume":"28","author":"McNeill","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2018.07.002_bib7","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/01.CIR.0000080897.52664.94","article-title":"Metabolic syndrome with and without c-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.dsx.2018.07.002_bib8","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.2337\/diabetes.52.5.1210","article-title":"Ncep-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older","volume":"52","author":"Alexander","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2018.07.002_bib9","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1464-5491.1999.00059.x","article-title":"Comment on the provisional report from the who consultation. European Group for the study of Insulin Resistance (EGIR)","volume":"16","author":"Balkau","year":"1999","journal-title":"Diabet Med"},{"key":"10.1016\/j.dsx.2018.07.002_bib10","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1007\/s00125-008-1052-6","article-title":"Diabetes mellitus among young adults in Sri Lanka\u2013role of gad antibodies in classification and treatment: the Sri Lanka Young Diabetes Study","volume":"51","author":"Katulanda","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.dsx.2018.07.002_bib11","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/clinchem\/39.5.773","article-title":"International Federation of Clinical Chemistry Standardization Project for measurements of apolipoproteins A-I and B. III. Comparability of apolipoprotein A-I values by use of international reference material","volume":"39","author":"Marcovina","year":"1993","journal-title":"Clin Chem"},{"key":"10.1016\/j.dsx.2018.07.002_bib12","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/clinchem\/40.4.586","article-title":"International Federation of Clinical Chemistry Standardization Project for measurements of apolipoproteins A-I and B. IV. Comparability of apolipoprotein b values by use of international reference material","volume":"40","author":"Marcovina","year":"1994","journal-title":"Clin Chem"},{"key":"10.1016\/j.dsx.2018.07.002_bib13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.dsx.2018.07.002_bib14","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1093\/clinchem\/43.12.2364","article-title":"Apolipoprotein B and AI distributions in the United States, 1988-1991: results of the national Health and nutrition examination Survey III (NHANES III)","volume":"43","author":"Bachorik","year":"1997","journal-title":"Clin Chem"},{"key":"10.1016\/j.dsx.2018.07.002_bib15","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1161\/01.CIR.0000038419.53000.D6","article-title":"Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy","volume":"106","author":"Grundy","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.dsx.2018.07.002_bib16","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.2337\/dc06-1484","article-title":"The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes","volume":"30","author":"Tong","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2018.07.002_bib17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0168-8510(01)00211-1","article-title":"Health sector reform in South Asia: new challenges and constraints","volume":"60","author":"Islam","year":"2002","journal-title":"Health Pol"},{"key":"10.1016\/j.dsx.2018.07.002_bib18","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1161\/01.CIR.94.9.2146","article-title":"Predominance of dense low-density lipoprotein particles predicts angiographic benefit of therapy in the Stanford coronary risk intervention project","volume":"94","author":"Miller","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.dsx.2018.07.002_bib19","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2796.2005.01556.x","article-title":"Apolipoprotein b: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis","volume":"258","author":"Olofsson","year":"2005","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.dsx.2018.07.002_bib20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/01.CIR.94.3.273","article-title":"Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec Cardiovascular Study","volume":"94","author":"Lamarche","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.dsx.2018.07.002_bib21","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/01.ATV.0000197827.12431.d0","article-title":"The apolipoprotein B\/AI ratio and the metabolic syndrome independently predict risk for myocardial infarction in middle-aged men","volume":"26","author":"Lind","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.dsx.2018.07.002_bib22","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1161\/CIRCULATIONAHA.107.733428","article-title":"Impact of the metabolic syndrome on macrovascular and microvascular outcomes in type 2 diabetes mellitus: United Kingdom prospective diabetes study 78","volume":"116","author":"Cull","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.dsx.2018.07.002_bib23","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2796.2006.01643.x","article-title":"The apob\/apoa-i ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy\u2013a review of the evidence","volume":"259","author":"Walldius","year":"2006","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.dsx.2018.07.002_bib24","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.amjcard.2006.06.029","article-title":"Comparison of apolipoprotein-B\/apolipoprotein-AI in subjects with versus without the metabolic syndrome","volume":"98","author":"Sierra-Johnson","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.dsx.2018.07.002_bib25","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.dsx.2018.07.002_bib26","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jacc.2008.09.041","article-title":"Lipid profile, plasma apolipoproteins, and risk of a first myocardial infarction among Asians: an analysis from the INTERHEART study","volume":"53","author":"Karthikeyan","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.dsx.2018.07.002_bib27","first-page":"821","article-title":"Apolipoprotein B\/apolipoprotein A-I ratio in relation to various definitions of metabolic syndrome among Saudi patients with type 2 diabetes mellitus","volume":"29","author":"Alfadda","year":"2008","journal-title":"Saudi Med J"},{"key":"10.1016\/j.dsx.2018.07.002_bib28","first-page":"925650","article-title":"Association of the apolipoprotein B\/apolipoprotein A-I ratio, metabolic syndrome components, total cholesterol, and low-density lipoprotein cholesterol with insulin resistance in the population of Georgia","volume":"2014","author":"Makaridze","year":"2014","journal-title":"Internet J Endocrinol"},{"key":"10.1016\/j.dsx.2018.07.002_bib29","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ihj.2017.02.020","article-title":"Recent trends in epidemiology of dyslipidemias in India","volume":"69","author":"Gupta","year":"2017","journal-title":"Indian Heart J"},{"key":"10.1016\/j.dsx.2018.07.002_bib30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2796.2006.01616.x","article-title":"Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person\/ten-country panel","volume":"259","author":"Barter","year":"2006","journal-title":"J\u00a0Intern Med"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402118302303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402118302303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:09:53Z","timestamp":1761728993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402118302303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1871402118302303"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2018.07.002","relation":{},"ISSN":["1871-4021"],"issn-type":[{"type":"print","value":"1871-4021"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Among young Sri Lankan patients with diabetes, how do lipid profiles differ between those with and without metabolic syndrome?","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2018.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}